维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Sugrue DM"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study(BRITE)显示文摘	Grothey A Sugrue MM Purdie DM		0，，26：	1
2	Bevacizumab beyond first progression is associated with prolonged overall survival in metastaticcolorectal cancer: results from a large observational cohort study (BRiTE) 显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Onco2008，26，33：	1
3	Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112 显示文摘	Prod'homme V Sugrue DM Stanton RJ Nomoto A Davies J Rickards CR Cochrane D Moore M Wilkinson GW Tomasec P	2010	J Gen Virol2010，91，8：	1
4	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRiTE)显示文摘	Grothey A Sugrue MM Purdie DM		0，，33：	1
5	Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112显示文摘	Prod'homme V Sugrue DM Stanton RJ	2010	J Gen Virol2010，91，8：	1
6	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRiTE)显示文摘	Grothey A Sugrue MM Purdie DM		0，，33：	1
7	Histopathologic features of the floppy eyelid syndrome involvement of tarsal elastin 显示文摘	Netland PA Sugrue SP Albert DM	1994	Opthalmology1994，101，1：	1
8	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Oncol2008，26，33：	1
9	Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD 112显示文摘	Prod'homme V Sugrue DM Stanton RJ		0，，8：	1
10	Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112显示文摘	Prod' homme V Sugrue DM Stanton RJ	2010	J Gen Virol2010，91，8：	1
11	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer : Resuhs from a large observational cohort study (BRiTE) 显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Oncol2008，26，33：	1
12	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic eoloreetal cancer: results froro a large observational cohort study (BRiTE) 显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin 0ncol2008，26，33：	1
13	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study(BRiTE)显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Oncol2008，26，33：	1
14	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) 显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Oncol2008，26，33：	1
15	Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): results from the BRiTE observational cohort study显示文摘	Kozloff MF Sugrue MM Purdie DM	2008	J Clin Oncol2008，，：	1
16	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) 显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Oncol2008，26，33：	1
17	Bevacizumab be- yond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRITE)显示文摘	Grothey A Sugrue MM Purdie DM	2008	Clin Oncol2008，26，33：	1
18	Bevacizumab beyond first progressaion is associated with prolonged overall survival in metastatic colorectal cancer:Results from a large observational cohort study(BRiTE)显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Oncol2008，26，33：	1
19	Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRiTE)显示文摘	Grothey A Sugrue MM Purdie DM	2008	J Clin Oncol2008，26，33：	1
20	Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112显示文摘	Prod' homme V Sugrue DM Stanton RJ	2010	J Gen Virol2010，91，8：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示